Growth Metrics

ENDRA Life Sciences (NDRA) Non-Current Assets: 2016-2021

Historic Non-Current Assets for ENDRA Life Sciences (NDRA) over the last 5 years, with Sep 2021 value amounting to $844,073.

  • ENDRA Life Sciences' Non-Current Assets rose 45.11% to $844,073 in Q3 2021 from the same period last year, while for Sep 2021 it was $844,073, marking a year-over-year increase of 45.11%. This contributed to the annual value of $557,240 for FY2020, which is 13.09% down from last year.
  • Latest data reveals that ENDRA Life Sciences reported Non-Current Assets of $844,073 as of Q3 2021, which was down 6.17% from $899,592 recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Non-Current Assets registered a high of $899,592 during Q2 2021, and its lowest value of $211,345 during Q2 2018.
  • In the last 3 years, ENDRA Life Sciences' Non-Current Assets had a median value of $587,307 in 2020 and averaged $583,756.
  • As far as peak fluctuations go, ENDRA Life Sciences' Non-Current Assets decreased by 22.32% in 2018, and later skyrocketed by 146.02% in 2020.
  • ENDRA Life Sciences' Non-Current Assets (Quarterly) stood at $241,549 in 2017, then climbed by 13.12% to $273,233 in 2018, then skyrocketed by 134.66% to $641,170 in 2019, then decreased by 13.09% to $557,240 in 2020, then soared by 45.11% to $844,073 in 2021.
  • Its Non-Current Assets stands at $844,073 for Q3 2021, versus $899,592 for Q2 2021 and $547,380 for Q1 2021.